王晓川，桑迪亚医药技术（上海）有限公司董事长

　　Dr. Xiao chuan Wang Ph.D, Chairman & CEO, Sundia MediTech Company, Shanghai, China

　　Dr. Wang, female, specialized in molecular structure design of new drugs, graduated from the University of Chicago in 1989. After her Ph.D. training, she worked for 3 biotech companies in USA on R&D research and program management. She has 20 years experience in drug discovery and development for 14 different target, and successfully applied computer aided drug design, medicinal chemistry, compound library design and screening, and ADME analysis. She led teams of medicinal chemists, biologists, and pharmacologist to go through the whole process of drug discovery from 0 to clinical stages.

    In 2004, Dr. Wang founded Sundia MediTech Company in Shanghai, and has led Sundia to grow into a leading Chinese CRO company, especially in new drug discovery CRO services. Sundia was selected by the top VC investors as one of the“Most Valuable Companies for Investment in China”in 2007 and 2008, and was honored in Deloitte High Tech High Growth Companies Top 50 in China, and Top 500 in Asia Pacific.